Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Cohen Jonathan M — 20/20 Biolabs, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Cohen Jonathan M

Cohen Jonathan M

Director at 20/20 Biolabs, Inc. · on record since Feb 19, 2026
Chief Executive Officer at 20/20 Biolabs, Inc. · on record since Feb 19, 2026
10% owner at 20/20 Biolabs, Inc. · on record since Feb 19, 2026

Insider trading activity of Cohen Jonathan M

Transactions on record: 1; since Mar 4, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 4, 2026

Figures computed from official regulatory filings — methodology.

Companies where Cohen Jonathan M has traded

20/20 Biolabs, Inc.1 tx · Mar 4, 2026

Track record of Cohen Jonathan M

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Cohen Jonathan M

Co-insiders of Cohen Jonathan M

Baker Ron20/20 Biolabs, Inc.
Bergman Alan B.20/20 Biolabs, Inc.
COHEN RICHARD M20/20 Biolabs, Inc.
Compton John G.20/20 Biolabs, Inc.
Lebowitz Michael Saul20/20 Biolabs, Inc.
Reddy Prasanth20/20 Biolabs, Inc.
Rollins John Woodson20/20 Biolabs, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ross Michael A.20/20 Biolabs, Inc.

Zhou Jiming20/20 Biolabs, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
20/20 Biolabs, Inc.	Mar 4, 2026	AwardD	352,936	0.00 USD	$0	SEC